Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Health Insurance topic
No spam. Unsubscribe anytime.
District health-plan costs rise as specialty drugs and a $450,000 claim squeeze budget
Summary
USI consultants told the St. Charles Parish School Board committee that net medical claims are running above budget this year, driven by several large medical claims, increased pharmacy spend (about one-third of costs) and specialty drugs. A single premature-birth claim of about $450,574 hit in October; the district's stop-loss limit is $275,000.
Get email alerts on the Health Insurance topic
No spam. Unsubscribe anytime.
USI consultants David Babin and Jesse Babin presented a financial review of the district's self-funded health plan, saying claims are running above initial forecasts and pharmacy costs are a rising share of the total.
According to the presentation, the district's last full plan year had about $29.9 million in net claims; an annualized forecast through October shows net claims 11% higher than the prior year and a projected 5% over the current budget. Pharmacy spending accounts for roughly 32% of total medical spend, and the district expects several million dollars in RX rebates from its PBM, Optum.
The consultants flagged a $450,574 large medical claim in October that is likely to rise above $600,000; the district's stop-loss specific deductible is $275,000, so the district's exposure for that claim is limited to that amount while reinsurance covers the remainder. USI also attributed a cluster of late claims in August'9 to negotiations and delayed submissions from an Ashner provider; that timing produced an August'9/September spike in paid claims.
Specialty drugs and newer GLP-1 medications were discussed at length. The consultants noted high unit prices for some specialty biologics (examples given in the presentation: a biologic with per-script costs cited at $22,000 and others at $7,000—17,000) and said insurers and PBMs are still adjusting coverage and pricing; USI described prior authorization and step-therapy tools as existing controls but said plan-design changes will be considered in January.
Board members asked for a follow-up packet showing historical stop-loss ratios, multi-year trends, and proposed plan-design options. Administration and benefits staff agreed to return in January with scenario modeling and recommendations about whether to change stop-loss terms or premium equivalents.
Ending: The consultants completed the financial overview and indicated they would supply more detailed stop-loss history and plan-design scenarios at the January benefits review.

